The RE-COVER pooled analysis of the double dummy period (only the time when dabigatran was taken by the study group) revealed a reduction in major bleeding which almost reached statistical significance [ 17 ].
← all excerpts
Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents.
1
—
—